0001209191-20-049796.txt : 20200908 0001209191-20-049796.hdr.sgml : 20200908 20200908200109 ACCESSION NUMBER: 0001209191-20-049796 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200908 FILED AS OF DATE: 20200908 DATE AS OF CHANGE: 20200908 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Saik Andrew CENTRAL INDEX KEY: 0001616284 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38356 FILM NUMBER: 201165191 MAIL ADDRESS: STREET 1: 640 LEE ROAD CITY: CHESTERBROOK STATE: PA ZIP: 19087 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VYNE Therapeutics Inc. CENTRAL INDEX KEY: 0001566044 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 453757789 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 520 U.S. HIGHWAY 22, SUITE 204 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 BUSINESS PHONE: 800-775-7936 MAIL ADDRESS: STREET 1: 520 U.S. HIGHWAY 22, SUITE 204 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: Menlo Therapeutics Inc. DATE OF NAME CHANGE: 20180201 FORMER COMPANY: FORMER CONFORMED NAME: Menlo Therapeutics, Inc. DATE OF NAME CHANGE: 20170728 FORMER COMPANY: FORMER CONFORMED NAME: Tigercat Pharma, Inc. DATE OF NAME CHANGE: 20130104 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-09-08 0 0001566044 VYNE Therapeutics Inc. VYNE 0001616284 Saik Andrew 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807 0 1 0 0 Chief Financial Officer Common Stock 2020-09-08 4 P 0 40000 1.462 A 340000 D These shares were purchased in multiple transactions at prices ranging from $1.4499 to $1.4767 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. /s/ Mutya Harsch, attorney-in-fact for Andrew Saik 2020-09-08